Omniox was founded by Jonathan Winger, Stephen Cary.

Who are Omniox's investors?

Omniox's investors include EcoR1 Capital, Wavemaker Three-Sixty Health.

How much funding has Omniox raised?

Omniox has disclosed $35.4M raised across 3 of its 4 known rounds.

Where is Omniox headquartered?

Omniox is headquartered in San Francisco, US.

Omniox

San Francisco, US · Delaware corporation · 2 known investors

Find your way into Omniox

Omniox is an IND-stage biotherapeutics company developing its H-NOX platform into OMX oxygen delivery biologics that carry oxygen to hypoxic tissues where low oxygen levels drive disease. The company aims to treat a range of unmet medical needs by restoring normal tissue function.

Biotech Medical Devices

Founders & leadership

Jonathan WingerinCo-founder

Stephen CaryCo-founder

Board

Jeffrey S. SambergBoard director

Laurence MartonBoard directorPrecision Medicine at Wavemaker Three-Sixty Health

Mitchell MutzBoard director

John WesleyBoard director

Ajit ShahBoard director

Investors · 2

EcoR1 CapitalSan Francisco

Wavemaker Three-Sixty HealthreportedLos Angeles · $500K – $2M

Reported raises · per SEC filings

Form D private placements

$35.4M disclosed across 3 of 4 rounds · 2014–2026

▶$24.1MraisedMar 2026 · 93 investors · Other Technology

Rule 506(b)

Officers, directors & promoters on the filing

Jeffrey S. SambergDirector
Laurence MartonDirector
Mitchell MutzDirector
Jonathan WingerExecutive Officer, Director

Offering amount: $28.1M
Amount sold: $24.1M
First sale: Aug 2016
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$4.7MraisedJul 2016 · 29 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Stephen CaryExecutive Officer, Director
John WesleyDirector
Jeff SambergDirector
Ajit ShahDirector

Offering amount: $8.5M
Amount sold: $4.7M
First sale: Jul 2016
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$6.6MraisedJun 2014 · 21 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

John WesleyDirector
Jeff SambergDirector
Stephen CaryExecutive Officer, Director
Ajit ShahDirector

Offering amount: $6.6M
Amount sold: $6.6M
First sale: Jun 2014
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 1

by search overlap

Iomx4 shared keywordsiOmx Therapeutics is a biotech company developing novel cancer therapies. Based in Munich's Martinsried biotech hub, the company focuses on transforming cancer treatment through scientific research and collaborative innovation.

Companies competing with Omniox for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

Omniox has filed a notice of an exempt offering of securities to raise $28,063,773.00 in New Funding. - intelligence360intelligence360.news · Apr 2026

Omniox - Tech Company Profile - Gaebler.com Venture Capital Databasegaebler.com

Frequently asked questions

What does Omniox do?: Omniox is an IND-stage biotherapeutics company developing its H-NOX platform into OMX oxygen delivery biologics that carry oxygen to hypoxic tissues where low oxygen levels drive disease. The company aims to treat a range of unmet medical needs by restoring normal tissue function.
Who founded Omniox?: Omniox was founded by Jonathan Winger, Stephen Cary.
Who are Omniox's investors?: Omniox's investors include EcoR1 Capital, Wavemaker Three-Sixty Health.
How much funding has Omniox raised?: Omniox has disclosed $35.4M raised across 3 of its 4 known rounds.
Where is Omniox headquartered?: Omniox is headquartered in San Francisco, US.